Endurant Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Hold |
0
| – | – | – | 55 |
|
|
2023
Q2 | – | Sell |
-762,264
| Closed | -$6.75M | – | 54 |
|
|
2023
Q1 | $6.75M | Buy |
+762,264
| New | +$6.75M | 3.47% | 9 |
|
|
2022
Q4 | – | Sell |
-179,226
| Closed | -$1.45M | – | 72 |
|
|
2022
Q3 | $1.45M | Sell |
179,226
-280,603
| -61% | -$2.26M | 0.47% | 37 |
|
|
2022
Q2 | $3.46M | Buy |
+459,829
| New | +$3.46M | 1.21% | 20 |
|
|
2019
Q1 | – | Sell |
-73,884
| Closed | -$1.14M | – | 83 |
|
|
2018
Q4 | $1.14M | Buy |
+73,884
| New | +$1.14M | 0.6% | 35 |
|
|
2017
Q4 | – | Sell |
-18,133
| Closed | -$319K | – | 87 |
|
|
2017
Q3 | $319K | Sell |
18,133
-44,700
| -71% | -$786K | 0.1% | 83 |
|
|
2017
Q2 | $2.09M | Buy |
62,833
+10,100
| +19% | +$335K | 0.59% | 44 |
|
|
2017
Q1 | $1.69M | Buy |
52,733
+28,800
| +120% | +$924K | 0.54% | 51 |
|
|
2016
Q4 | $868K | Sell |
23,933
-109,500
| -82% | -$3.97M | 0.36% | 54 |
|
|
2016
Q3 | $6.14M | Sell |
133,433
-97,100
| -42% | -$4.47M | 2.28% | 15 |
|
|
2016
Q2 | $11.6M | Sell |
230,533
-94,300
| -29% | -$4.74M | 3.87% | 7 |
|
|
2016
Q1 | $17.4M | Sell |
324,833
-5,200
| -2% | -$278K | 5.63% | 1 |
|
|
2015
Q4 | $21.7M | Buy |
330,033
+96,933
| +42% | +$6.36M | 7.24% | 1 |
|
|
2015
Q3 | $13.2M | Buy |
233,100
+44,300
| +23% | +$2.5M | 4.39% | 4 |
|
|
2015
Q2 | $11.2M | Buy |
188,800
+9,300
| +5% | +$550K | 3.29% | 10 |
|
|
2015
Q1 | $11.2M | Buy |
179,500
+46,600
| +35% | +$2.9M | 3.69% | 5 |
|
|
2014
Q4 | $7.64M | Buy |
+132,900
| New | +$7.64M | 3% | 9 |
|